首页 > 最新文献

Journal of Neuropsychology最新文献

英文 中文
Non-optimal cognitive offloading in schizophrenia in a prospective memory task: Influence of both metacognitive beliefs and cognitive effort avoidance 精神分裂症患者在前瞻性记忆任务中的非最佳认知卸载:元认知信念和认知努力回避的影响。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-11-18 DOI: 10.1111/jnp.12399
Amandine Décombe, Chiara Scarampi, Elora Malleville, Delphine Capdevielle, Sam J. Gilbert, Stéphane Raffard

Cognitive offloading refers to the use of physical action and the external environment to simplify mental demand. One form of this—intention offloading—involves the use of external reminders to support delayed intentions. Both beliefs of poor memory ability and a preference to avoid cognitive effort lead to offloading intentions rather than using internal memory. Schizophrenia is a population with deficits in prospective memory and to overcome this difficulty, neuropsychological interventions can propose external aids such as reminders. However, it is unknown what motivates individuals with schizophrenia to spontaneously use reminders. Twenty-seven individuals with schizophrenia and twenty-seven non-clinical individuals were recruited to perform a prospective memory task, with two levels of difficulty, by deciding whether to use reminders or their internal memory. The proportion of reminder use, performance (hits and errors), subjective effort and metacognitive beliefs were recorded. The results show a non-optimal use of reminders in the schizophrenia group: this group used more reminders than the non-clinical group when the task was easy but did not increase reminder usage when the task became more difficult. Individuals with schizophrenia perceived the task to be more effortful than the non-clinical individuals in the easy task, but also had a high estimation of their memory ability. Reminder usage in schizophrenia is atypical and non-optimal. This may relate to effort and metacognition but the direct influence of these factors remains to be demonstrated. The overall results open perspectives on the neuropsychological treatment of prospective memory in this population.

认知卸载指的是利用实际行动和外部环境来简化心理需求。其中一种形式--意向卸载--涉及使用外部提醒来支持延迟的意向。记忆能力差的信念和避免认知努力的偏好都会导致意向卸载,而不是使用内部记忆。精神分裂症患者在前瞻性记忆方面存在缺陷,为了克服这一困难,神经心理学干预措施可以提供外部帮助,如提醒。然而,精神分裂症患者自发使用提醒器的动机是什么尚不得而知。研究人员招募了27名精神分裂症患者和27名非临床患者,让他们通过决定使用提醒器还是内部记忆来完成一项有两种难度的前瞻性记忆任务。研究人员记录了使用提醒器的比例、表现(命中和错误)、主观努力和元认知信念。结果表明,精神分裂症组对提醒器的使用并不理想:当任务简单时,该组比非临床组使用更多的提醒器,但当任务变得更加困难时,提醒器的使用并没有增加。在完成简单任务时,精神分裂症患者认为比非临床患者更费力,但他们对自己的记忆能力也有很高的评价。精神分裂症患者对提醒的使用是非典型和非最佳的。这可能与努力和元认知有关,但这些因素的直接影响仍有待证实。总体结果为该人群前瞻性记忆的神经心理学治疗提供了新的视角。
{"title":"Non-optimal cognitive offloading in schizophrenia in a prospective memory task: Influence of both metacognitive beliefs and cognitive effort avoidance","authors":"Amandine Décombe,&nbsp;Chiara Scarampi,&nbsp;Elora Malleville,&nbsp;Delphine Capdevielle,&nbsp;Sam J. Gilbert,&nbsp;Stéphane Raffard","doi":"10.1111/jnp.12399","DOIUrl":"10.1111/jnp.12399","url":null,"abstract":"<p>Cognitive offloading refers to the use of physical action and the external environment to simplify mental demand. One form of this—intention offloading—involves the use of external reminders to support delayed intentions. Both beliefs of poor memory ability and a preference to avoid cognitive effort lead to offloading intentions rather than using internal memory. Schizophrenia is a population with deficits in prospective memory and to overcome this difficulty, neuropsychological interventions can propose external aids such as reminders. However, it is unknown what motivates individuals with schizophrenia to spontaneously use reminders. Twenty-seven individuals with schizophrenia and twenty-seven non-clinical individuals were recruited to perform a prospective memory task, with two levels of difficulty, by deciding whether to use reminders or their internal memory. The proportion of reminder use, performance (hits and errors), subjective effort and metacognitive beliefs were recorded. The results show a non-optimal use of reminders in the schizophrenia group: this group used more reminders than the non-clinical group when the task was easy but did not increase reminder usage when the task became more difficult. Individuals with schizophrenia perceived the task to be more effortful than the non-clinical individuals in the easy task, but also had a high estimation of their memory ability. Reminder usage in schizophrenia is atypical and non-optimal. This may relate to effort and metacognition but the direct influence of these factors remains to be demonstrated. The overall results open perspectives on the neuropsychological treatment of prospective memory in this population.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"216-233"},"PeriodicalIF":1.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alzheimer's disease—Biomarkers, clinical evaluation or both? 阿尔茨海默病--生物标志物、临床评估还是两者兼而有之?
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-11-14 DOI: 10.1111/jnp.12401
Joel Simrén, Nicholas J. Ashton, Marc Suárez-Calvet, Henrik Zetterberg
<p>Recent developments in fluid and imaging biomarkers that reflect the key pathological hallmarks of Alzheimer's disease (AD)—deposits of extracellular amyloid-β (Aβ) and intracellular tau proteins—have transformed the perception of the disease in living individuals from a clinical syndrome to a biological continuum that begins prior to the onset of symptoms (Scheltens et al., <span>2021</span>). Over the past two decades, biomarker research has revealed that Aβ deposition and abnormal tau metabolism begin years before symptoms appear, following a predictable sequence of biological changes (Bateman et al., <span>2012</span>; Villemagne et al., <span>2013</span>). This suggests a prolonged preclinical phase of the disease. Biomarkers, which have greatly expanded our understanding of disease progression, are now routinely applied in clinical settings. These include Food and Drug Administration (FDA)-approved positron emission tomography (PET) imaging agents of Aβ plaques and tau aggregates, cerebrospinal fluid (CSF) measures of Aβ and phosphorylated tau (p-tau), and soon, plasma measures of tau forms phosphorylated at amino acid 217 (p-tau217).</p><p>As AD neuropathology is the defining hallmark of the disease (Hyman et al., <span>2012</span>), as well as being the target of emerging treatments, recently approved in some countries (Cummings et al., <span>2023</span>), it is reasoned that biomarkers that directly reflect these changes should be the defining features of the disease. This view was formally articulated in the recent publication of novel Alzheimer's Association diagnostic and staging criteria for AD, which suggest that the disease can be diagnosed when a so-called ‘Core 1’ biomarker of Aβ proteinopathy or phosphorylated and secreted tau is abnormal, resulting in a purely biological definition of the disease (Jack et al., <span>2024</span>). In prior years, studies have shown that PET detect Aβ (Clark et al., <span>2012</span>) and tau (Fleisher et al., <span>2020</span>) neuropathology with high (~90%) accuracy. CSF tests of Aβ42/40 and Aβ42/p-tau (Janelidze et al., <span>2017</span>) have been validated against amyloid PET with similar accuracy, and subsequently also neuropathology (Mattsson-Carlgren et al., <span>2022</span>). Over the past 5 years, an expanding body of research indicates that plasma p-tau217 can detect Aβ pathology with high accuracy (Ashton et al., <span>2023</span>, <span>2024</span>; Schindler et al., <span>2024</span>), which will improve the access to biological AD diagnoses in clinical settings beyond what health care systems are currently scaled to accommodate.</p><p>The recently published diagnostic and staging criteria (Jack et al., <span>2024</span>) are a development of the criteria published by the National Institute of Aging and Alzheimer's Association (NIA-AA) in 2018, which aimed to establish a common language for further research in the biological evolution of AD and its relation to resulting symptom
反映阿尔茨海默病(AD)关键病理特征的流体和成像生物标志物(细胞外淀粉样蛋白-β (a β)和细胞内tau蛋白沉积)的最新进展,已将活个体对该疾病的认知从临床综合征转变为在症状发作之前开始的生物连续体(Scheltens等人,2021)。在过去的二十年中,生物标志物研究表明,a β沉积和异常tau代谢在症状出现前几年就开始了,遵循可预测的生物学变化序列(Bateman等,2012;Villemagne et al., 2013)。这表明该疾病的临床前阶段较长。生物标志物,极大地扩展了我们对疾病进展的理解,现在被常规地应用于临床环境。这些包括美国食品和药物管理局(FDA)批准的Aβ斑块和tau聚集体的正电子发射断层扫描(PET)显像剂,脑脊液(CSF)测量Aβ和磷酸化tau (p-tau),以及很快,血浆测量氨基酸217磷酸化的tau形式(p-tau217)。由于阿尔茨海默病的神经病理学是该疾病的决定性标志(Hyman et al., 2012),也是一些国家最近批准的新兴治疗方法的目标(Cummings et al., 2023),因此有理由认为直接反映这些变化的生物标志物应该是该疾病的决定性特征。这一观点在最近发表的阿尔茨海默病协会的新AD诊断和分期标准中得到了正式阐述,该标准表明,当a β蛋白病或磷酸化和分泌的tau蛋白的所谓“Core 1”生物标志物异常时,可以诊断出该疾病,从而导致该疾病的纯生物学定义(Jack等人,2024)。前几年的研究表明,PET检测Aβ (Clark et al., 2012)和tau (Fleisher et al., 2020)神经病理学具有很高(~90%)的准确性。a - β42/40和a - β42/p-tau的脑脊液测试(Janelidze等人,2017)已经在淀粉样PET上得到了类似的准确性验证,随后也得到了神经病理学的验证(Mattsson-Carlgren等人,2022)。在过去的5年中,越来越多的研究表明血浆p-tau217可以高精度地检测Aβ病理(Ashton et al., 2023,2024;Schindler等人,2024),这将改善临床环境中生物AD诊断的可及性,超出目前卫生保健系统的规模。最近发表的诊断和分期标准(Jack et al., 2024)是对美国国家衰老与阿尔茨海默病协会(NIA-AA)于2018年发布的标准的发展,旨在为进一步研究阿尔茨海默病的生物进化及其与由此产生的症状学的关系建立一种共同语言(Jack et al., 2018)。与该文件一样,在最近的标准中,临床分期方案作为疾病定义的补充(Jack et al., 2024)。最近的标准还增加了一个生物学分期方案,表明tau PET(“Core 2生物标志物”;包括有前途的尽管是探索性的tau聚集体流体生物标志物;Horie等人,2023)与Aβ PET结合使用,用于对疾病进行生物学分期,因为tau聚集物与症状有更密切的关系(Ossenkoppele等人,2018)。在这些标准之前的另一个关键发展是,最近FDA全面批准了lecanemab (van Dyck等人,2023年)和donanemab (Sims等人,2023年),现在世界其他地区的其他几个监管机构也批准了这两种药物。这些试验依赖于谨慎使用基于生物标志物的纳入,确保个体具有治疗所针对的病理(即Aβ病理)。在一些早期失败的试验中,情况并非如此,在这些试验中,阿尔茨海默氏症是临床定义的,这意味着诊断与生物标志物状态无关。在其中一项试验中,相当大比例的研究参与者被发现为a β阴性(Salloway et al., 2014),因此可能被误诊。换句话说,为了成功地治疗疾病的生物学,疾病的定义必须基于其潜在的生物学。此外,血浆p-tau217和胶质纤维酸性蛋白(GFAP;一种反映胶质细胞激活的星形胶质蛋白)在临床试验中显示出对抗a β药物的反应,这表明它们可以用作靶标参与生物标志物(Pontecorvo等人,2022;Sims et al., 2023)。进一步支持这一点的是,脑脊液和成像生物标志物以及分子神经病理学的最新进展,使该领域能够获得更多关于神经心理学测量、症状学和生物标志物/神经病理学发现之间关系的知识。这些研究发现,通常与AD病理相关的经典遗忘综合征可能是由于边缘显性年龄相关性TDP-43脑病(LATE)所致(Nelson等)。 (2019)在很大比例的病例中,特别是在最年长的老年患者中。相反,原发性进行性失语(Bergeron等人,2018)、行为/执行障碍综合征(Ossenkoppele等人,2015)、皮质基底综合征(Lee等人,2011)和后皮质萎缩(Alladi等人,2007)等综合征也可能与AD的潜在病理有关。众所周知,个体可能表现为多种病理(Robinson et al., 2018),对病理有不同的认知恢复力(Stern, 2012),有疾病进展的遗传修饰因子(Van Cauwenberghe et al., 2016),或者具有与阿尔茨海默氏症不典型相关的症状(例如认知症状的波动,在路易体痴呆中很常见),这可以反映在临床阶段和生物学阶段的分离(Jack et al., 2024)。然而,再一次,如果阳性生物标志物与临床表现不一致,这并不意味着疾病不存在。另一方面,需要仔细的临床判断来确定哪种病理最可能解释症状。阿尔茨海默病生物学定义的批评者表示,这些新标准将能够检测出患有阿尔茨海默病的无症状个体,尽管尚不确定他们最终是否会因该疾病而出现症状。然而,阿尔茨海默病协会的标准强调,目前AD可以但不应该在没有认知症状(临床阶段1)的个体中被诊断出来(Jack et al., 2024),同样的推理也适用于大多数有主观认知症状的个体(即没有客观损害;临床阶段2),因为没有批准的治疗方法用于这一群体,并且这些病例的疾病患病率较低,因此阳性预测值较低,导致更高的假阳性结果和不必要的调查和焦虑(Hansson &amp;杰克,2024)。如果正在进行的临床前AD试验取得成功,这种情况可能会改变(Rafii等人,2023),导致与心血管疾病(例如治疗高血压或降脂)或2型糖尿病(治疗无症状高血糖)相当的情况。在缺乏此类治疗方法的情况下,我们认为目前应仅在有症状的个体中使用生物标志物诊断AD,同时进行仔细的临床评估,因为这种疾病的检测前概率较高,并且后果可行(例如,有症状的治疗和在一些国家的疾病改善治疗)。正在制定关于如何以及何时诊断AD的具体工作流程和基于场景的指南。未来的研究非常重要,以增加对AD是某一患者症状的原因的信心,包括验证反映tau聚集体的液体生物标志物(即提供与tau PET相似的信息)。脑脊液测量微管结合区(MTBR) tau已显示出可喜的结果(Horie等人,2023;Salvado等,2024)和脑脊液或血浆中氨基酸205处的p-tau (p-tau205) (Gobom等,2022;Lantero-Rodriguez et al., 2024;Montoliu-Gaya, Alosco等,2023;Montoliu-Gaya, Benedet等,2023),它比反映
{"title":"Alzheimer's disease—Biomarkers, clinical evaluation or both?","authors":"Joel Simrén,&nbsp;Nicholas J. Ashton,&nbsp;Marc Suárez-Calvet,&nbsp;Henrik Zetterberg","doi":"10.1111/jnp.12401","DOIUrl":"10.1111/jnp.12401","url":null,"abstract":"&lt;p&gt;Recent developments in fluid and imaging biomarkers that reflect the key pathological hallmarks of Alzheimer's disease (AD)—deposits of extracellular amyloid-β (Aβ) and intracellular tau proteins—have transformed the perception of the disease in living individuals from a clinical syndrome to a biological continuum that begins prior to the onset of symptoms (Scheltens et al., &lt;span&gt;2021&lt;/span&gt;). Over the past two decades, biomarker research has revealed that Aβ deposition and abnormal tau metabolism begin years before symptoms appear, following a predictable sequence of biological changes (Bateman et al., &lt;span&gt;2012&lt;/span&gt;; Villemagne et al., &lt;span&gt;2013&lt;/span&gt;). This suggests a prolonged preclinical phase of the disease. Biomarkers, which have greatly expanded our understanding of disease progression, are now routinely applied in clinical settings. These include Food and Drug Administration (FDA)-approved positron emission tomography (PET) imaging agents of Aβ plaques and tau aggregates, cerebrospinal fluid (CSF) measures of Aβ and phosphorylated tau (p-tau), and soon, plasma measures of tau forms phosphorylated at amino acid 217 (p-tau217).&lt;/p&gt;&lt;p&gt;As AD neuropathology is the defining hallmark of the disease (Hyman et al., &lt;span&gt;2012&lt;/span&gt;), as well as being the target of emerging treatments, recently approved in some countries (Cummings et al., &lt;span&gt;2023&lt;/span&gt;), it is reasoned that biomarkers that directly reflect these changes should be the defining features of the disease. This view was formally articulated in the recent publication of novel Alzheimer's Association diagnostic and staging criteria for AD, which suggest that the disease can be diagnosed when a so-called ‘Core 1’ biomarker of Aβ proteinopathy or phosphorylated and secreted tau is abnormal, resulting in a purely biological definition of the disease (Jack et al., &lt;span&gt;2024&lt;/span&gt;). In prior years, studies have shown that PET detect Aβ (Clark et al., &lt;span&gt;2012&lt;/span&gt;) and tau (Fleisher et al., &lt;span&gt;2020&lt;/span&gt;) neuropathology with high (~90%) accuracy. CSF tests of Aβ42/40 and Aβ42/p-tau (Janelidze et al., &lt;span&gt;2017&lt;/span&gt;) have been validated against amyloid PET with similar accuracy, and subsequently also neuropathology (Mattsson-Carlgren et al., &lt;span&gt;2022&lt;/span&gt;). Over the past 5 years, an expanding body of research indicates that plasma p-tau217 can detect Aβ pathology with high accuracy (Ashton et al., &lt;span&gt;2023&lt;/span&gt;, &lt;span&gt;2024&lt;/span&gt;; Schindler et al., &lt;span&gt;2024&lt;/span&gt;), which will improve the access to biological AD diagnoses in clinical settings beyond what health care systems are currently scaled to accommodate.&lt;/p&gt;&lt;p&gt;The recently published diagnostic and staging criteria (Jack et al., &lt;span&gt;2024&lt;/span&gt;) are a development of the criteria published by the National Institute of Aging and Alzheimer's Association (NIA-AA) in 2018, which aimed to establish a common language for further research in the biological evolution of AD and its relation to resulting symptom","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"165-171"},"PeriodicalIF":1.8,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12401","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolving the problem of surface dyslexia in Italian through inflection of irregular verbs 通过不规则动词的变位解决意大利语表层阅读障碍问题。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-11-14 DOI: 10.1111/jnp.12400
Daniele Licciardo, Valeria Isella, Elisa Canu, Marta Forestiero, Veronica Castelnovo, Stefania Valsecchi, Federica Agosta, Massimo Filippi, Ildebrando Appollonio, Peter J Nestor

Surface dyslexia and dysgraphia are considered diagnostic features of semantic variant primary progressive aphasia (svPPA) and are useful signs in English, a language whose attributes afford numerous opportunities to observe these phenomena. This, however, is not the case in many languages, including Italian, that have high transparency between orthography and phonology, making surface reading and spelling errors scarce. This creates a problem in applying the diagnostic recommendations for svPPA in such languages. Surface dyslexia and dysgraphia are examples of ‘regularization’ errors in which semantic knowledge loss leads to a failure to recognize exceptions that do not follow standard rules of pronunciation. Another form of regularization involves the incorrect inflection of irregular verbs using the rules that govern regular verbs. Unlike irregularly pronounced words, Italian, as with many languages, has numerous irregular verbs. The Italian Verb Inflection Test (IVIT) was developed to test the hypothesis that svPPA would regularize irregular verbs when inflecting them into two Italian past tenses. Results confirmed that people with svPPA made a significantly greater proportion of regularization errors compared to people with typical Alzheimer's disease or logopenic variant PPA. Without recourse to the other diagnostic features of PPA subgroups, the IVIT on its own could separate svPPA from these other two groups with 70% sensitivity and ~ 80% specificity. Regularization of irregular verb inflection offers a solution to the problem of applying the surface dyslexia/dysgraphia criterion for svPPA diagnosis in Italian.

表面阅读障碍和书写障碍被认为是语义变异型原发性进行性失语症(svPPA)的诊断特征,在英语中是有用的标志,因为英语的特性为观察这些现象提供了大量机会。然而,包括意大利语在内的许多语言却并非如此,因为意大利语的正字法和语音学之间的透明度很高,表面阅读和拼写错误很少。这就给在这类语言中应用 svPPA 诊断建议带来了问题。表面阅读障碍和书写障碍是 "正则化 "错误的例子,其中语义知识的缺失导致无法识别不遵循标准发音规则的例外情况。另一种 "规则化 "错误是使用规则动词的规则对不规则动词进行错误的变形。与不规则发音的单词不同,意大利语和许多语言一样,有许多不规则动词。我们开发了意大利语动词变位测试(IVIT),以检验 svPPA 在将不规则动词变位为两种意大利语过去式时,是否会将其规则化的假设。结果证实,与典型阿尔茨海默病或对数变异型 PPA 患者相比,svPPA 患者的规则化错误比例明显更高。在不考虑 PPA 亚群的其他诊断特征的情况下,IVIT 本身就能将 svPPA 与其他两类患者区分开来,灵敏度为 70%,特异度约为 80%。不规则动词变音的正规化为应用表面阅读障碍/书写障碍标准进行意大利语 svPPA 诊断提供了一个解决方案。
{"title":"Resolving the problem of surface dyslexia in Italian through inflection of irregular verbs","authors":"Daniele Licciardo,&nbsp;Valeria Isella,&nbsp;Elisa Canu,&nbsp;Marta Forestiero,&nbsp;Veronica Castelnovo,&nbsp;Stefania Valsecchi,&nbsp;Federica Agosta,&nbsp;Massimo Filippi,&nbsp;Ildebrando Appollonio,&nbsp;Peter J Nestor","doi":"10.1111/jnp.12400","DOIUrl":"10.1111/jnp.12400","url":null,"abstract":"<p>Surface dyslexia and dysgraphia are considered diagnostic features of semantic variant primary progressive aphasia (svPPA) and are useful signs in English, a language whose attributes afford numerous opportunities to observe these phenomena. This, however, is not the case in many languages, including Italian, that have high transparency between orthography and phonology, making surface reading and spelling errors scarce. This creates a problem in applying the diagnostic recommendations for svPPA in such languages. Surface dyslexia and dysgraphia are examples of ‘regularization’ errors in which semantic knowledge loss leads to a failure to recognize exceptions that do not follow standard rules of pronunciation. Another form of regularization involves the incorrect inflection of irregular verbs using the rules that govern regular verbs. Unlike irregularly pronounced words, Italian, as with many languages, has numerous irregular verbs. The Italian Verb Inflection Test (IVIT) was developed to test the hypothesis that svPPA would regularize irregular verbs when inflecting them into two Italian past tenses. Results confirmed that people with svPPA made a significantly greater proportion of regularization errors compared to people with typical Alzheimer's disease or logopenic variant PPA. Without recourse to the other diagnostic features of PPA subgroups, the IVIT on its own could separate svPPA from these other two groups with 70% sensitivity and ~ 80% specificity. Regularization of irregular verb inflection offers a solution to the problem of applying the surface dyslexia/dysgraphia criterion for svPPA diagnosis in Italian.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"234-246"},"PeriodicalIF":1.8,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12400","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142613238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing confusion surrounding expert conceptions of Alzheimer's and dementia: A practical analysis 减少专家对阿尔茨海默氏症和痴呆症概念的混淆:实用分析。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-10-25 DOI: 10.1111/jnp.12398
Timothy Daly, Ignacio Mastroleo

Biological, clinicobiological and clinical conceptions of Alzheimer's disease and related dementias are being promoted simultaneously to different practical ends. The co-existence of contemporary conceptions and the ‘scary label’ associated with older diagnostic criteria create the possibility of misunderstanding and harm. In this comment, we argue in favour of socio-ethical interventions targeted to health workers and the general public so as to lower the uncertainties introduced by contemporary diagnostic criteria and to articulate how they relate to established criteria.

为了不同的实际目的,阿尔茨海默病和相关痴呆症的生物学、临床生物学和临床概念正在同时得到推广。现代概念和与旧诊断标准相关的 "可怕标签 "并存,有可能造成误解和伤害。在这篇评论中,我们主张针对医务工作者和公众采取社会伦理干预措施,以降低当代诊断标准带来的不确定性,并阐明这些标准与既定标准的关系。
{"title":"Reducing confusion surrounding expert conceptions of Alzheimer's and dementia: A practical analysis","authors":"Timothy Daly,&nbsp;Ignacio Mastroleo","doi":"10.1111/jnp.12398","DOIUrl":"10.1111/jnp.12398","url":null,"abstract":"<p>Biological, clinicobiological and clinical conceptions of Alzheimer's disease and related dementias are being promoted simultaneously to different practical ends. The co-existence of contemporary conceptions and the ‘scary label’ associated with older diagnostic criteria create the possibility of misunderstanding and harm. In this comment, we argue in favour of socio-ethical interventions targeted to health workers and the general public so as to lower the uncertainties introduced by contemporary diagnostic criteria and to articulate how they relate to established criteria.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"158-164"},"PeriodicalIF":1.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12398","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142491712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and validation of the abbreviated Prefrontal Symptoms Inventory (PSI-20): A tool for assessing prefrontal symptoms in English-speaking populations 前额叶症状调查表(PSI-20)缩写本的翻译和验证:用于评估英语国家人群前额叶症状的工具。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-10-10 DOI: 10.1111/jnp.12397
María A. Sosa, Eduardo J. Pedrero-Pérez, José M. Ruiz-Sánchez de León

This study introduces the translation and validation of the Prefrontal Symptoms Inventory (PSI) into English, aiming to provide an ecologically valid tool for assessing prefrontal symptoms in English-speaking populations in the United States. The prefrontal cortex (PFC) plays a crucial role in executive functions and other higher-order cognitive processes, with dysfunctions in this area associated with various cognitive, emotional and behavioural changes. Despite the existence of established tools like the Dysexecutive Questionnaire (DEX), the PSI addresses limitations found in the literature, presenting a novel ecologically valid tool for assessing prefrontal symptoms. The current study, involving 226 English-speaking participants, lays a foundational step for validating the PSI for use in a new population. Semi-confirmatory factorial analysis revealed a unidimensional structure, mirroring the Spanish version with robust fit indicators. Additionally, in assessing convergent validity, the abbreviated version (PSI-20) exhibited high correlations with DEX scores and moderate correlations with Psychological Stress Scale and General Health Questionnaire-12 scores. These findings align with previous reports, supporting the PSI-20's measurement of similar constructs related to prefrontal cortex activity and mental health components. The results of this study overall highlight the PSI's potential contribution to advancing prefrontal symptom evaluation in clinical and non-clinical settings.

本研究介绍了前额叶症状量表(PSI)的英语翻译和验证,旨在为美国的英语人群提供一种生态学上有效的前额叶症状评估工具。前额叶皮层(PFC)在执行功能和其他高阶认知过程中起着至关重要的作用,该区域的功能障碍与各种认知、情绪和行为变化有关。尽管有执行障碍问卷(DEX)等成熟的工具,但 PSI 解决了文献中发现的局限性,为评估前额叶症状提供了一种新的生态学上有效的工具。本研究涉及 226 名英语参与者,为验证 PSI 在新人群中的使用奠定了基础。半确认性因子分析显示了一个单维度结构,与西班牙语版本一致,并具有稳健的拟合指标。此外,在评估收敛效度时,缩略版(PSI-20)与 DEX 分数呈高度相关,与心理压力量表和一般健康问卷-12 分数呈中度相关。这些结果与之前的报告一致,支持 PSI-20 测量与前额叶皮层活动和心理健康成分相关的类似构念。这项研究的结果从总体上强调了 PSI 在临床和非临床环境中推进前额叶症状评估的潜在贡献。
{"title":"Translation and validation of the abbreviated Prefrontal Symptoms Inventory (PSI-20): A tool for assessing prefrontal symptoms in English-speaking populations","authors":"María A. Sosa,&nbsp;Eduardo J. Pedrero-Pérez,&nbsp;José M. Ruiz-Sánchez de León","doi":"10.1111/jnp.12397","DOIUrl":"10.1111/jnp.12397","url":null,"abstract":"<p>This study introduces the translation and validation of the Prefrontal Symptoms Inventory (PSI) into English, aiming to provide an ecologically valid tool for assessing prefrontal symptoms in English-speaking populations in the United States. The prefrontal cortex (PFC) plays a crucial role in executive functions and other higher-order cognitive processes, with dysfunctions in this area associated with various cognitive, emotional and behavioural changes. Despite the existence of established tools like the Dysexecutive Questionnaire (DEX), the PSI addresses limitations found in the literature, presenting a novel ecologically valid tool for assessing prefrontal symptoms. The current study, involving 226 English-speaking participants, lays a foundational step for validating the PSI for use in a new population. Semi-confirmatory factorial analysis revealed a unidimensional structure, mirroring the Spanish version with robust fit indicators. Additionally, in assessing convergent validity, the abbreviated version (PSI-20) exhibited high correlations with DEX scores and moderate correlations with Psychological Stress Scale and General Health Questionnaire-12 scores. These findings align with previous reports, supporting the PSI-20's measurement of similar constructs related to prefrontal cortex activity and mental health components. The results of this study overall highlight the PSI's potential contribution to advancing prefrontal symptom evaluation in clinical and non-clinical settings.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"200-215"},"PeriodicalIF":1.8,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142454308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive assessment: More important than ever 认知评估:比以往任何时候都更重要。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-10-02 DOI: 10.1111/jnp.12396
Stefano F. Cappa
{"title":"Cognitive assessment: More important than ever","authors":"Stefano F. Cappa","doi":"10.1111/jnp.12396","DOIUrl":"10.1111/jnp.12396","url":null,"abstract":"","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"154-157"},"PeriodicalIF":1.8,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142363627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From neuropsychology to embodied neuroscience: Introduction to the special issue on body representation and body transformations 从神经心理学到具身神经科学:身体表征与身体转换特刊导言。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-09-23 DOI: 10.1111/jnp.12395
Paul M. Jenkinson, Valentina Moro
{"title":"From neuropsychology to embodied neuroscience: Introduction to the special issue on body representation and body transformations","authors":"Paul M. Jenkinson,&nbsp;Valentina Moro","doi":"10.1111/jnp.12395","DOIUrl":"10.1111/jnp.12395","url":null,"abstract":"","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 S1","pages":"1-7"},"PeriodicalIF":1.8,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Memory problems in elderly people with traumatic brain injury 脑外伤老人的记忆问题。
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-09-20 DOI: 10.1111/jnp.12393
Dimitar Monov, Nikolay Lilyanov

The aim of this study is to assess the effectiveness of various therapy methods in elderly individuals with traumatic brain injury (TBI), taking into account the degree of memory loss and the severity of the injury. The study was conducted in 2022 in Moscow, Russia, and Sofia, Bulgaria, involving six clinics. A total of 200 elderly patients with TBI participated in the study, with a mean age of 72 years. Patients were categorized into groups based on the degree of memory loss and severity of the injury. Standardized tests, including the Mini-Mental State Examination (MMSE), Clock Drawing Test, Digit Symbol Substitution Test, and Free, and Cued Selective Reminding Test, were used to assess cognitive functions. The Progressive Learning Test evaluated patients' ability to memorize and reproduce information over time. Groups receiving physical therapy and cognitive rehabilitation showed statistically significant improvement in cognitive functions compared to other therapy methods. Specifically, the mean score of the MMSE in these groups increased by 7 points (p < .001). Patients with more severe memory loss demonstrated more pronounced improvement in cognitive functions following the integrated therapy approach. The mean MMSE score increased by 10 points (p < .001), whereas in patients with milder memory loss, the growth was less significant (mean increase of 5 points, p < .05). Groups receiving physical therapy and cognitive rehabilitation consistently demonstrated significantly better results compared to speech therapy and psychological support throughout the study period.

本研究的目的是评估各种治疗方法对患有创伤性脑损伤(TBI)的老年人的有效性,同时考虑到记忆丧失的程度和损伤的严重性。研究于 2022 年在俄罗斯莫斯科和保加利亚索非亚进行,涉及六家诊所。共有 200 名患有创伤性脑损伤的老年患者参与了研究,他们的平均年龄为 72 岁。根据记忆丧失的程度和受伤的严重程度,患者被分为不同的组别。研究采用了标准化测试来评估患者的认知功能,包括小型精神状态检查(MMSE)、时钟绘制测试、数字符号替换测试、自由和提示选择性记忆测试。渐进学习测试评估了患者在一段时间内记忆和重现信息的能力。与其他治疗方法相比,接受物理治疗和认知康复治疗的小组在认知功能方面有显著的改善。具体来说,这些小组的 MMSE 平均得分提高了 7 分(p
{"title":"Memory problems in elderly people with traumatic brain injury","authors":"Dimitar Monov,&nbsp;Nikolay Lilyanov","doi":"10.1111/jnp.12393","DOIUrl":"10.1111/jnp.12393","url":null,"abstract":"<p>The aim of this study is to assess the effectiveness of various therapy methods in elderly individuals with traumatic brain injury (TBI), taking into account the degree of memory loss and the severity of the injury. The study was conducted in 2022 in Moscow, Russia, and Sofia, Bulgaria, involving six clinics. A total of 200 elderly patients with TBI participated in the study, with a mean age of 72 years. Patients were categorized into groups based on the degree of memory loss and severity of the injury. Standardized tests, including the Mini-Mental State Examination (MMSE), Clock Drawing Test, Digit Symbol Substitution Test, and Free, and Cued Selective Reminding Test, were used to assess cognitive functions. The Progressive Learning Test evaluated patients' ability to memorize and reproduce information over time. Groups receiving physical therapy and cognitive rehabilitation showed statistically significant improvement in cognitive functions compared to other therapy methods. Specifically, the mean score of the MMSE in these groups increased by 7 points (<i>p</i> &lt; .001). Patients with more severe memory loss demonstrated more pronounced improvement in cognitive functions following the integrated therapy approach. The mean MMSE score increased by 10 points (<i>p</i> &lt; .001), whereas in patients with milder memory loss, the growth was less significant (mean increase of 5 points, <i>p</i> &lt; .05). Groups receiving physical therapy and cognitive rehabilitation consistently demonstrated significantly better results compared to speech therapy and psychological support throughout the study period.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"186-199"},"PeriodicalIF":1.8,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual self-face and self-body recognition in a left-brain-damaged prosopagnosic patient 左脑受损的前视患者的视觉自我面部和自我身体识别能力
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-09-18 DOI: 10.1111/jnp.12391
Carlotta Casati, Lorenzo Diana, Sara Casartelli, Luigi Tesio, Giuseppe Vallar, Nadia Bolognini

The present case study describes the patient N.G., who reported prosopagnosia along with difficulty in recognising herself in the mirror following a left-sided temporo-occipital hemispheric stroke. The neuropsychological and experimental investigation revealed only a mild form of apperceptive prosopagnosia, without visual agnosia, primarily caused by an impaired visual processing of face-parts and body parts but not of full faces. Emotional expressions did not modulate her face processing. On the other hand, N.G. showed a marked impairment of visual self-recognition, as assessed with visual matching-to-sample tasks, both at the level of body-part and face-part processing and at a full-face level, featured by a deficit in the perceptual discrimination of her own face and body, as compared to the others' face and body. N.G.'s lesion mapping showed damage to the left inferior occipito-temporal cortex, affecting the inferior occipital gyrus and compromising long-range connections between the occipital/temporo-occipital areas and the anterior fronto-temporal areas. Overall, the present case report documents that visual processing of the person's own face may be selectively compromised by a left-sided hemispheric lesion disconnecting extra-striate body- and face-selective visual areas to self-representation regions. Moreover, others' (full) face processing may be preserved, as compared with the impaired ability to discriminate others' body and face parts.

本病例研究描述的患者 N.G. 在左侧颞枕叶半球中风后,报告患有嗜脸症,并且难以从镜子中认出自己。神经心理学和实验调查显示,N.G 患有轻微的感知型嗜脸症,但没有视觉失认症,主要原因是对脸部和身体部位的视觉处理能力受损,而不是对完整脸部的视觉处理能力受损。情绪表达并不影响她对面部的处理。另一方面,N.G.表现出明显的视觉自我识别障碍,通过视觉匹配样本任务进行评估,无论是在身体部分和面部部分的处理层面,还是在整个面部的处理层面,其特点是与他人的面部和身体相比,她对自己的面部和身体的感知辨别能力存在缺陷。N.G.的病灶图显示,她的左枕颞下皮层受损,影响了枕下回,并损害了枕/颞/颞区与前颞区之间的长程连接。总之,本病例报告表明,由于左侧大脑半球病变,斑状体外身体和脸部选择性视觉区域与自我表现区域之间的连接断开,对自己脸部的视觉处理可能会受到选择性损害。此外,与分辨他人身体和脸部的能力受损相比,对他人(全部)脸部的处理可能会得到保留。
{"title":"Visual self-face and self-body recognition in a left-brain-damaged prosopagnosic patient","authors":"Carlotta Casati,&nbsp;Lorenzo Diana,&nbsp;Sara Casartelli,&nbsp;Luigi Tesio,&nbsp;Giuseppe Vallar,&nbsp;Nadia Bolognini","doi":"10.1111/jnp.12391","DOIUrl":"10.1111/jnp.12391","url":null,"abstract":"<p>The present case study describes the patient N.G., who reported prosopagnosia along with difficulty in recognising herself in the mirror following a left-sided temporo-occipital hemispheric stroke. The neuropsychological and experimental investigation revealed only a mild form of apperceptive prosopagnosia, without visual agnosia, primarily caused by an impaired visual processing of face-parts and body parts but not of full faces. Emotional expressions did not modulate her face processing. On the other hand, N.G. showed a marked impairment of visual self-recognition, as assessed with visual matching-to-sample tasks, both at the level of body-part and face-part processing and at a full-face level, featured by a deficit in the perceptual discrimination of her own face and body, as compared to the others' face and body. N.G.'s lesion mapping showed damage to the left inferior occipito-temporal cortex, affecting the inferior occipital gyrus and compromising long-range connections between the occipital/temporo-occipital areas and the anterior fronto-temporal areas. Overall, the present case report documents that visual processing of the person's own face may be selectively compromised by a left-sided hemispheric lesion disconnecting extra-striate body- and face-selective visual areas to self-representation regions. Moreover, others' (full) face processing may be preserved, as compared with the impaired ability to discriminate others' body and face parts.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 S1","pages":"97-112"},"PeriodicalIF":1.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity and reliability of the Mobile Toolbox Faces and Names memory test 移动工具箱面孔和姓名记忆测试的有效性和可靠性
IF 1.8 4区 心理学 Q2 PSYCHOLOGY Pub Date : 2024-09-17 DOI: 10.1111/jnp.12394
Dorene M. Rentz, Jerry Slotkin, Aaron J. Kaat, Stephanie Ruth Young, Elizabeth M. Dworak, Yusuke Shono, Hubert Adam, Cindy J. Nowinski, Sarah Pila, Miriam A. Novack, Zahra Hosseinian, Saki Amagai, Maria Varela Diaz, Anyelo Almonte-Correa, Keith Alperin, Monica R. Camacho, Bernard Landavazo, Rachel L. Nosheny, Michael W. Weiner, Richard C. Gershon

Validation of the Mobile Toolbox Faces and Names associative memory test is presented. Ninety-two participants self-administered Faces and Names in-person; 956 self-administered Faces and Names remotely but took convergent measures in person; and 123 self-administered Faces and Names remotely twice, 14 days apart. Internal consistency (.76–.79) and test–retest reliability (ICC = .73) were acceptable. Convergent validity with WMS-IV Verbal Paired Associates was satisfactory (immediate .54; delayed .58). The findings suggest the remotely administered Faces and Names is a reliable instrument.

本文介绍了移动工具箱 "面孔和名字 "联想记忆测试的验证情况。92名参与者亲自进行了 "面孔和名字 "的自我测试;956名参与者通过远程方式进行了 "面孔和名字 "的自我测试,但亲自进行了会聚测量;123名参与者通过远程方式进行了 "面孔和名字 "的自我测试,两次测试相隔14天。内部一致性(.76-.79)和测试再测可靠性(ICC = .73)均可接受。与 WMS-IV 言语配对联想的收敛效度令人满意(即时.54;延迟.58)。研究结果表明,远程管理的 "面孔和名字 "是一种可靠的工具。
{"title":"Validity and reliability of the Mobile Toolbox Faces and Names memory test","authors":"Dorene M. Rentz,&nbsp;Jerry Slotkin,&nbsp;Aaron J. Kaat,&nbsp;Stephanie Ruth Young,&nbsp;Elizabeth M. Dworak,&nbsp;Yusuke Shono,&nbsp;Hubert Adam,&nbsp;Cindy J. Nowinski,&nbsp;Sarah Pila,&nbsp;Miriam A. Novack,&nbsp;Zahra Hosseinian,&nbsp;Saki Amagai,&nbsp;Maria Varela Diaz,&nbsp;Anyelo Almonte-Correa,&nbsp;Keith Alperin,&nbsp;Monica R. Camacho,&nbsp;Bernard Landavazo,&nbsp;Rachel L. Nosheny,&nbsp;Michael W. Weiner,&nbsp;Richard C. Gershon","doi":"10.1111/jnp.12394","DOIUrl":"10.1111/jnp.12394","url":null,"abstract":"<p>Validation of the Mobile Toolbox Faces and Names associative memory test is presented. Ninety-two participants self-administered Faces and Names in-person; 956 self-administered Faces and Names remotely but took convergent measures in person; and 123 self-administered Faces and Names remotely twice, 14 days apart. Internal consistency (.76–.79) and test–retest reliability (ICC = .73) were acceptable. Convergent validity with WMS-IV Verbal Paired Associates was satisfactory (immediate .54; delayed .58). The findings suggest the remotely administered Faces and Names is a reliable instrument.</p>","PeriodicalId":197,"journal":{"name":"Journal of Neuropsychology","volume":"19 2","pages":"390-396"},"PeriodicalIF":1.8,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jnp.12394","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Neuropsychology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1